Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE study
Titel:
Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE study
Auteur:
Lataillade, Max Lalezari, Jacob P Kozal, Michael Aberg, Judith A Pialoux, Gilles Cahn, Pedro Thompson, Melanie Molina, Jean-Michel Moreno, Santiago Grinsztejn, Beatriz Diaz, Ricardo S Castagna, Antonella Kumar, Princy N Latiff, Gulam H De Jesus, Edwin Wang, Marcia Chabria, Shiven Gartland, Margaret Pierce, Amy Ackerman, Peter Llamoso, Cyril